EU drug markets report: a strategic analysis
EMCDDA, Lisbon, January 2013
Publication type:
Joint publications
Summary:
The EU drug markets report is the first comprehensive overview of illicit drug markets in the European Union. It covers issues such as production, consumer markets, trafficking, organised crime and policy responses, along with a review of the markets for heroin, cocaine, cannabis, amphetamine, methamphetamine, ecstasy and new psychoactive substances. It concludes with concrete action points for the areas where the current EU response to the drug market and its consequent harms may be improved.
An essential reference tool for law enforcement professionals, policymakers, the academic community and the general public, the report combines Europol’s strategic and operational understanding of trends and developments in organised crime with the EMCDDA’s ongoing monitoring and analysis of the drug phenomenon in Europe and beyond.
Table of contents
- Foreword
- Introduction
- Acknowledgements
- At a glance
- Chapter 1: Context
- Chapter 2: Heroin
- Chapter 3: Cocaine
- Chapter 4: Cannabis
- Chapter 5: Amphetamine
- Chapter 6: Methamphetamine
- Chapter 7: Ecstasy
- Chapter 8: New psychoactive substances
- Chapter 9: Issues in focus
- Chapter 10: Conclusions and recommendations
- References
- Abbreviations
Case studies
Case study 1
Cannabis: changing demand and an increase in domestic production
Case study 2
Methamphetamine production and trafficking increasing in Europe
Case study 3
New psychoactive substances: 73 detected in 2012
Case study 4
Twenty-seven arrested as European police dismantle drug smuggling network
Case study 5
Synthetic drugs network broken up
Case study 6
6.5 tonnes of heroin precursor seized
Case study 7
Case study 8
Price:
freeISBN/ISSN:
978-92-9168-595-0
